A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferipron-desferrioxamine versus deferasirox

Eitemau Tebyg

• A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy
  gan: Pepe, Alessia, et al.
  Cyhoeddwyd: (2011)
• A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
  gan: Pepe, Alessia, et al.
  Cyhoeddwyd: (2011)
• Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
  gan: Pepe, Alessia, et al.
  Cyhoeddwyd: (2011)
• Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging
  gan: Pepe, Alessia, et al.
  Cyhoeddwyd: (2011)
• Deferiprone or deferasirox for cardiac siderosis in β thalassemia major (reply)
  gan: Pepe, Alessia, et al.
  Cyhoeddwyd: (2011)